Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics
Volume 2: Diagnostic and Therapeutic Applications

Edited by Ranbir Chander Sobti,Aastha Sobti,Awtar Krishan Ganju,Haruhiko Sugimura

ISBN13: 9780323951142

Imprint: Academic Press Inc

Publisher: Elsevier Science & Technology

Format: Paperback / softback

Published: 15/09/2023

Availability: Not yet available

Description
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case. This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
UNIT 1: Tumor invading nervous system 1. Introduction 2. Epidemiology 3. Signs and symptoms 4. Specific Advancements 5. Treatment Types UNIT 2: Head and neck cancer 6. Advances in Screening 7. Early detection and treatment strategies UNIT 3: Oral and GI tract cancers (including Colon) 8. Incidence 9. Etiology and genetic predisposition 10. Nutritional impact 11. Role of gut microbes 12. Diagnostic markers 13. Treatment protocols and response UNIT 4: Lung cancer 14. Predisposition markers including etiological factors 15. Diagnostic molecular markers 16. Genetic basis of population variations 17. Treatment protocols and response UNIT 5: Cancer affecting upper aero duct 18. Introduction 19. p53 and other pathway and targets 20. Risk factors associated 21. Prognostics 22. Conclusion UNIT 6: Leukemias 23. Introduction 24. Role of Bcr-Abl and other variants 25. Philadelphia translocation: molecular basis and implications 26. Epidemiology 27. Prognostic markers UNIT 7: Breast and uterine cancer 28. Introduction 29. Etiological markers 30. Role of estrogen 31. Phytoestrogen 32. Conclusion UNIT 8: Gastric Cancer 33. Introduction 34. Epidemiology 35. Predisposition markers 36. Signs and symptoms 37. Prognostic protocols 38. Prevention 39. Treatment UNIT 9: Hepatocellular carcinoma 40. Introduction 41. Molecular epidemiology 42. Signs and symptoms 43. Diagnostic markers 44. Prevention 45. Treatment UNIT 10: Human Papilloma Virus in Cervical and other cancers 46. Introduction 47. Molecular aspects of HPV including screening technologies 48. Etiological aspects 49. Signs and symptoms of cancers associated with HPV 50. Prevention 51. Treatments available including vaccines UNIT 11: Urogenital Tract Cancers 52. Bladder 53. Kidney 54. Prostate 55. Testicular 56. Ovarian 57. Molecular markers in their predisposition diagnosis, etiological factors, and treatment protocols and treatment responses UNIT 12: Rare cancers catching up with common cancers: A case of biliary tract cancer genetics with special emphasis on Gallbladder carcinoma UNIT 13: Molecular Pathogenesis of Gallbladder Cancer: Translational Implications UNIT 14: Assessing role of GWAS identified various mutations, e.g. 5p15.33 and 8q24.21 genetic variants in gallbladder cancer 58. Predisposition 59. Treatment response and 60. Toxicity in North-Indian population
  • Medical bioinformatics
  • Biomedical engineering
  • Enterprise software
  • Oncology
  • Professional & Vocational
Height:
Width:
Spine:
Weight:0.00
List Price: £127.00